Axillary nodal status is one of the most important prognostic factors in breast cancer. While
sentinel lymph node biopsy (SLNB) is a safe and validated procedure for clinically node …

Axillary lymph node (LN) metastasis is the most important predictor of overall recurrence and
survival in patients with breast cancer, and accurate assessment of axillary LN involvement …

Sentinel lymph node biopsy (SLNB) is the standard of care for axillary staging in clinically
node-negative (cN0) breast cancer patients without neoadjuvant chemotherapy (NAC). The …

Breast cancer patients who present with nodal metastasis receive neoadjuvant
chemotherapy (NAC) with increasing frequency and can have complete pathologic …

Axillary nodal status is an important prognostic factor in guiding locoregional and systemic
treatment for breast cancer. Sentinel lymph node biopsy (SNB) has revolutionized axillary …

Simple Summary Breast cancer is the most frequent cancer affecting women, and axillary
lymph nodes (ALNs) are the most common initial site of metastatic spread. In patients with …

Sentinel lymph node biopsy (SLNB) is widely employed to detect axillary lymph node
metastases in breast cancer patients with clinically negative (N0) axillae. One of the few …

Background Clinical evaluation of the axilla is an area of controversy in current breast
cancer research and management. Evidence of axillary metastasis on biopsy affects all …

Identifying the presence of axillary node and internal mammary node metastases in patients
with invasive breast cancer is critical for determining prognosis and for deciding on …

According to the available data, sentinel lymph node (SLN) biopsy is proving to be an
accurate staging technique with less post-surgical morbidity than standard axillary lymph …